Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study

OBJECTIVE: The management experience for plasma cell leukemia (PCL) is still limited by PCL’s rare incidence and aggressive course. The goal of this study was to further identify the efficacy of bortezomib-containing regimens for PCL in Chinese patients. MATERIALS AND METHODS: In this study, 56 cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huijuan, Zhou, Huixing, Zhang, Zhiyao, Geng, Chuanying, Chen, Wenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236418/
https://www.ncbi.nlm.nih.gov/pubmed/31769277
http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236418/
https://www.ncbi.nlm.nih.gov/pubmed/31769277
http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0254

Ejemplares similares